2007
DOI: 10.1293/tox.20.237
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Novel Mouse Anaphylaxis Model Produced by Intermittent Intravenous Injections of Ovalbumin without Adjuvant

Abstract: Abstract:This study was performed to develop mouse anaphylaxis model using ovalbumin (OA) as an antigen, with no adjuvant, and an intravenous route of administration. OA at dose levels from 0.5 to 500 mg/kg was injected 3 times into the tail vein of female CD-1 (ICR) mice at 4-day intervals. Clinical signs and extravasation of Evans blue dye (vascular permeability) were observed, serum histamine levels and airway resistance were measured, and histopathological examinations were performed. Furthermore, to detec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…We further ruled out the role of penicillin-specific IgE in vascular leakage. The passive cutaneous anaphylaxis (PCA) test is a standard method of measuring allergen-specific IgE antibody levels in allergy mouse models 32 . As a positive control, ovalbumin (OVA) induced a 100% positive response, whereas no visible reaction was observed in penicillin-treated groups ( Table 1 ).…”
Section: Resultsmentioning
confidence: 99%
“…We further ruled out the role of penicillin-specific IgE in vascular leakage. The passive cutaneous anaphylaxis (PCA) test is a standard method of measuring allergen-specific IgE antibody levels in allergy mouse models 32 . As a positive control, ovalbumin (OVA) induced a 100% positive response, whereas no visible reaction was observed in penicillin-treated groups ( Table 1 ).…”
Section: Resultsmentioning
confidence: 99%